重视慢性肝病的病情评估

doi:10.3969/j.issn.1672-5069.2017.01.002

Abstract

Chen Liuying, Lu Lungen.. Evaluation of chronic liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 4-6.

[1] Wang Y,Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J,2015,128（2）:252-258.
[2] Castéra L,Vergniol J,Foucher J,et al. Prospective comparison of transient elastography,fibrotest,APRI,and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology,2005,128（2）:343-350.
[3] Foucher J,Chanteloup E,Vergniol J,et al. Diagnosis of cirrhosis by transient elastography （FibroScan）:a prospective study. Gut,2006,55（3）:403-408.
[4] Nierhoff J,Chavez Ortiz AA,Herrmann E,et al. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis:a meta-analysis. Eur Radiol,2013,23（11）:3040-3053.
[5] Ichikawa S,Motosugi U,Ichikawa T,et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magnet Reson Med Sci,2012,11（4）:291-297.
[6] Chen J,Talwalkar J A,Yin M,et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology,2011,259（3）: 749-756.
[7] Motosugi U,Ichikawa T,Sano K,et al. Magnetic resonance elastography of the liver:preliminary results and estimation of inter-rater reliability. Jap J Radiol,2010,28（8）:623-627.
[8] Jarcuska P,Janicko M,Veseliny E,et al. Circulating markers of liver fibrosis progression. Clinica Chim Acta,2010,411（15-16）: 1009-1017.
[9] Qi X,Liu X,Zhang Y,et al. Serum liver fibrosis markers in the prognosis of liver cirrhosis:A prospective observational study. Med Sci Moni,2016,22:2720-2730.
[10] Seki E,Schwabe R F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology （Baltimore,Md）, 2015,61（3）:1066-1079.
[11] Corpechot C,Barbu V,Wendum D,et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology （Baltimore, Md）,2002,35（5）:1010-1021.
[12] Tamimi TI,Elgouhari HM,Alkhouri N,et al. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol,2011,54（6）:1224-1229.
[13] Bantel H,Lugering A,Heidemann J,et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology （Baltimore,Md）,2004,40（5）:1078-1087.
[14] Deng YQ,Zhao H,Ma AL,et al. Selected cytokines serve as potential biomarkers for predicting liver inflammation and fibrosis in chronic hepatitis B patients with normal to mildly elevated aminotransferases . Medicine,2015,94（45）:e2003.
[15] Kakumu S,Okumura A,Ishikawa T,et al. Serum levels of IL-10,IL-15 and soluble tumour necrosis factor-alpha （TNF-
alpha） receptors in type C chronic liver disease. Clin Experiment Immunol,1997,109（3）:458-463.
[16] Bader El Din N G,Farouk S,El-Shenawy R,et al. Tumor necrosis factor-alpha-G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. World J Gastroenterol,2016,22（34）:7767-7777.
[17] Papatheodoridis G V,Hadziyannis E,Tsochatzis E,et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-
negative chronic hepatitis B virus infection. Gut,2008,57（4）:500-506.
[18] Han L H,Sun W S,Ma C H,et al. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol,2002,8（6）:1077-1080.
[19] Antoine D J,Dear J W,Lewis P S,et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology （Baltimore,Md）,2013,58（2）:777-787.
[20] Sharara A I,Rockey D C. Gastroesophageal variceal hemorrhage. New Engl J Med,2001,345（9）:669-681.
[21] Lee S W,Lee T Y,Chang C S. Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci,2009,54（5）:1128-1134.
[22] European Association for the Study of The L. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis. J Hepatol,2010,53（3）:397-417.
[23] Piroth L,Pechinot A,Di Martino V,et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis:a two-year observational study. BMC Infect Dis,2014,14:287.
[24] Oliveira AM,Branco JC,Barosa R,et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis:a multicenter cohort study. Eur J Gastroenterol Hepatol,2016,28（10）:1216-1222.
[25] Nischalke HD,Berger C,Aldenhoff K,et al. Toll-like receptor （TLR） 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol,2011,55（5）:1010-1016.
[26] Lutz P,Berger C,Langhans B,et al. A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis. Dig Liver Dis,2014,46（11）1047-1050.

Evaluation of chronic liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments

[1]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[2]	Ba Zhengwu, Li Hailong, Yang Hui. Quantitative evaluation of hepatic function by EDCT in patients with Budd-Chiari syndrome before and after TIPS [J]. Journal of Practical Hepatology, 2019, 22(5): 680-683.
[3]	Ba Zhengwu, Li Hailong. Application of multi-slice spiral CT portography in evaluation of liver functions in patients with liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 397-400.
[4]	Yan Chenli, Wang Jingjing, Wang Jun.. Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
[5]	Shi Peng, Wang Kun, Shen Junchun, et al. Application of computed tomography scan in evaluating therapeutic effect of transcatheter arterial chemoembolization in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 253-256.
[6]	Wang Yanxin, Yu Hongwei, Zhu Yueke. Nutritional assessment and treatment in patients with chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 317-320.
[7]	Li Xuefeng, Li Jiansheng, Ma Jinliang, et al.. Application of indocyanine green clearance test, single photon emission computed tomography and three-dimensional reconstruction in patients with primary liver cancer before hemihepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 477-480.
[8]	Hu Ye, Zhang Guo.. Diagnosis, severity assessment of hepatic fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 13-16.
[9]	Ma Zhenzeng, Lu Lungen. Nonalcoholic fatty liver disease and liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 135-138.
[10]	Yang Jinhui, Tang Yingmei. Evaluation of interventional therapy for patients with hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 230-232.
[11]	Zeng Jing, Fan Jiangao. Spleen stiffness measurement in non-invasive diagnosis of patients with chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 209-212.
[12]	Wang Baifang, Wang Ying, Wang Bingyuan, et al.. Improvement of laboratory index by magnesium isoglycyrrhizinate in patients with chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(3): 235-237.
[13]	WEI Ping，ZHANG Jianao，JIE Shenghua，et al.. Effects of ornithine aspartate granules on the level of serum gamma-glutamyltransferase in patients with chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(6): 422-423.
[14]	LI Zhenzhi, WANG Xiaohua, WANG Liming, et al.. Analysis on the correlation between liver MRI scores and clinical severity in viral hepatitis-induced cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(2): 107-108.